{"organizations": [], "uuid": "29b82308772c836e13d12bd87c540f0bf9db1567", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/06/globe-newswire-leanlife-adds-chief-operating-officer.html", "country": "US", "domain_rank": 767, "title": "LeanLife Adds Chief Operating Officer", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.018, "site_type": "news", "published": "2018-03-06T21:59:00.000+02:00", "replies_count": 0, "uuid": "29b82308772c836e13d12bd87c540f0bf9db1567"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/06/globe-newswire-leanlife-adds-chief-operating-officer.html", "ord_in_thread": 0, "title": "LeanLife Adds Chief Operating Officer", "locations": [], "entities": {"persons": [{"name": "elizabeth liu", "sentiment": "none"}, {"name": "liu", "sentiment": "none"}], "locations": [{"name": "british columbia", "sentiment": "none"}], "organizations": [{"name": "leanlife health inc.", "sentiment": "negative"}, {"name": "globe newswire", "sentiment": "negative"}, {"name": "flora group of companies", "sentiment": "none"}, {"name": "basham thompson & liu llp", "sentiment": "none"}, {"name": "omega", "sentiment": "none"}, {"name": "link business law group", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "VANCOUVER, British Columbia, March 06, 2018 (GLOBE NEWSWIRE) -- LeanLife Health Inc. (the “Company”) (CSE:LLP) is pleased to announce that Elizabeth Liu, QC, has been appointed Chief Operating Officer.\nMs. Liu will be responsible for managing operations of all aspects of the Company’s flax seed-based Omega 3 products. Her 27-year career to date includes roles in strategic planning, direct oversight of operations in the natural health products sector, and commercial law.\nMs. Liu founded and is Managing Director of LINK Business Law Group, which meets the needs of corporate clients by providing a broad range of legal, strategic and risk management advice, as well as general counsel services. Clients include both early-stage and established companies in a variety of industries.\nPrior to establishing LINK Business Law Group, Ms. Liu was Managing Partner at Basham Thompson & Liu LLP. She then served as Vice President and General Counsel of the Flora Group of Companies where she was involved in all aspects of the group’s operations and provided guidance on contracts and other legal issues. Flora manufactures and sells premium natural health products and has numerous distributorships in international markets.\nMs. Liu was appointed Queen’s Counsel by Order-in-Council in December 2016.\n“Elizabeth Liu brings a valuable skillset to LeanLife and we see her playing a very important role as our company moves toward commercialization,” said Stan Lis, Chief Executive Officer of LeanLife Health. “It is essential to have the right strategy in place and the ability to execute that strategy so high-quality LeanLife products are marketed, produced, and further developed in a timely, cost-effective fashion. We are extremely pleased that Elizabeth has chosen to bring her experience to our team at such a key point in LeanLife’s development.”\nAbout LeanLife Health and the Omega 3 Market\nLeanLife Health’s products are extracted from flax seeds, a plentiful and non-animal source of Omega 3. The products can be used as a food additive or as a nutraceutical and have been used to make bread, noodles, cheese, yogurt, juice and milk products for the European market. LeanLife Health’s industry leading Omega 3 product formulations are of the highest quality and contain no cholesterol. Products are available in oil, emulsion and powder forms.\nThe global omega 3 market is expected to reach USD 7.32 billion by 2020, according to a report by Grand View Research, Inc.\nFor more information, please contact:\nStan Lis, CEO\nTel: 604 764-0518\nE-mail: slis@leenlifepharma.com\nForward Looking Information\nInformation set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control including, the Company's ability to compete with large food companies; sales of any potential products developed will be profitable; the ability to complete sales under the sales agreement. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.\nTHE CSE HAS NEITHER APPROVED NOR DISAPPROVED THE INFORMATION CONTAINED HEREIN AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE\nSource:LeanLife Health", "external_links": ["https://www.globenewswire.com/Tracker?data=N7PcUWdJo5m70VutHUJawjNYMK0u74qHnVuuccatuc1v9A7VA2bXVLofNvb30tgxOmab5OJ82e2ptLjYKaF1UxHGllWDfyhecu4OijM3Z8vQgI6GhOVkSNDP_M-amrfKQejuyDM2e5HP9ZR8oKfYtw==", "https://www.globenewswire.com/NewsRoom/AttachmentNg/11481919-d8b3-44a7-bd9d-8ea4bf1502ed"], "published": "2018-03-06T21:59:00.000+02:00", "crawled": "2018-03-06T23:17:12.000+02:00", "highlightTitle": ""}